Over the past decade, the rise of cancer immunotherapy has coincided with a remarkable breakthrough in cancer therapy, which attracted increased interests in public. The scientific community clearly showed that the emergence of immunotherapy is an inevitable outcome of a holistic approach for cancer treatment. It is well established that traditional Chinese medicine (TCM) utilizes the principle of homeostasis and balance to adjust the healthy status of body. TCM treatment toward cancer has a long history, and the diagnosis and treatment of tumors were discussed in the ancient and classical literatures of Chinese medicine, such as the Yellow Emperor’s Inner Canon. Precious heritage has laid the foundation for the innovation and development of cancer treatment with TCM. The modern study indicated that TCM facilitates the treatment of cancer and enhances the survival rate and life expectancy of patients. However, the pharmacological mechanisms underlying these effects are not yet completely understood. In addition, physicians cannot always explain why the TCM treatment is effective and the mechanism of action cannot be explained in scientific terms. Here, we attempted to provide insights into the development of TCM in the treatment and interpret how TCM practitioners treat cancer through six general principles of TCM by using modern scientific language and terms based on newly discovered evidence.

This study delineated the characteristics of 24 (11.2%) culture-positive, influenza-associated pulmonary aspergillosis (IAPA) patients out of 215 patients with severe influenza during 2016–2019 in a medical center in southern Taiwan. Twenty (83.3%) patients did not have EORTC/MSG-defined host factors. The mean time from influenza diagnosis to Aspergillus growth was 4.4 days, and 20 (83.3%) developed IAPA within seven days after influenza diagnosis. All patients were treated in intensive care units and all but one (95.8%) received mechanical ventilation. Aspergillus tracheobronchitis was evident in 6 (31.6%) of 19 patients undergoing bronchoscopy. Positive galactomannan testing of either serum or bronchoalveolar lavage was noted in all patients. On computed tomography imaging, IAPA was characterized by peribronchial infiltrates, multiple nodules, and cavities superimposed on ground-glass opacities. Pure Aspergillus growth without bacterial co-isolation in culture was found in 17 (70.8%) patients. A. fumigatus (15, 62.5%), A. flavus (6, 25.0%), and A. terreus (4, 16.7%) were the major causative species. Three patients had mixed Aspergillus infections due to two species, and two had mixed azole-susceptible and azole-resistant A. fumigatus infection. All patients received voriconazole with an all-cause mortality of 41.6%. Of 14 survivors, the mean duration of antifungal use was 40.5 days. In conclusion, IAPA is an early and rapidly deteriorating complication following influenza that necessitates clinical vigilance and prompt diagnostic workup.

No abstract

Two novel sulfonate phenol ligands—3,3′‐di‐tert‐butyl‐2′‐hydroxy‐5,5′,6,6′‐tetramethyl‐biphenyl‐2‐yl 4‐X‐benzenesulfonate (XCF3, LCF3‐H, and XOCH3, LOMe‐H)—were prepared through the sulfonylation of 3,3′‐di‐tert‐butyl‐5,5′,6,6′‐tetramethylbiphenyl‐2,2′‐diol with the corresponding 4‐substituted benzenesulfonyl chloride (1 equiv.) in the presence of excess triethylamine. Magnesium (Mg) complexes supported by sulfonate phenoxide ligands were synthesized and characterized structurally. The reaction of MgnBu2 with L‐H (2 equiv.) produces the four‐coordinated monomeric complexes (LCF3)2Mg (1) and (LOMe)2Mg (2). Complexes 1 and 2 are efficient catalysts for the ring‐opening polymerization of ε‐caprolactone (ε‐CL) and trimethylene carbonate (TMC) in the presence of 9‐anthracenemethanol; complex 1 catalyzes the polymerization of ε‐CL and TMC in a controlled manner, yielding polymers with the expected molecular weights and narrow polydispersity indices (PDIs). In ε‐CL polymerization, the activity of complex 1 is greater than that of complex 2, likely because of the greater Lewis acidity of Mg2+ metal caused by the electron‐withdrawing substitute trifluoromethyl (CF3) at the 4‐position of the benzenesulfonate group. © 2010 Wiley Periodicals, Inc. J Polym Sci Part A: Polym Chem 48: 3564–3572, 2010

No abstract